AUPH icon

Aurinia Pharmaceuticals
AUPH

Overview Fund Activity

25 hedge funds and large institutions have $18.1M invested in Aurinia Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
+10
Holders Change %
+66.67%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
4
Closed
4
Calls
$1.48M
Puts
$856K
Net Calls
+$627K
Net Calls Change
+$627K

Top Buyers

1
NMC
1
NEA Management Company
Maryland
$8.54M
2
ACP
2
Acuta Capital Partners
California
$2.1M
3
Goldman Sachs
3
Goldman Sachs
New York
$2.68M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.88M
5
AFM
5
Anson Funds Management
Texas
$815K

Top Sellers

1
A
1
Abingworth
United Kingdom
$0
2
RG
2
Redmile Group
California
$77K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
Creative Planning
4
Creative Planning
Kansas
$2K
5
VKH
5
Virtu KCG Holdings
New York
$26K
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– – -15,236 Closed
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
$0 4 -64 -94%
Simplex Trading
28
Simplex Trading
Illinois
– – – –
Group One Trading
29
Group One Trading
Illinois
– – – –
HT
30
HAP Trading
New York
– – – –
Bank of America
31
Bank of America
North Carolina
$0 100 +100 New
RFA
32
Reilly Financial Advisors
California
$0 100 +100 New
1
2